This inventor holds 7 USPTO granted patents and 4 published patent applications. Top assignees: Brown University, Yale University. Active years: 2011-2023.
Location History:
- Bramford, CT (US) (2011)
- Branford, CT (US) (2012 - 2023)
Company Filing History:
Years Active: 2011-2023
Title: The Innovative Contributions of Bing Ma in Cancer Treatment
Introduction
Bing Ma is a remarkable inventor based in Branford, Connecticut, who has made significant strides in the field of cancer treatment through his innovative work. With a portfolio of seven patents, Ma has developed groundbreaking methods and compositions that address critical challenges in oncology.
Latest Patents
Ma's latest patents focus on the development of bispecific anti-CHI3L1 antibody reagents for the treatment of cancer. His research demonstrates that the combination of inhibitors of immune checkpoints and CHI3L1 can lead to synergistic effects in cancer therapy. This work describes methods and compositions for combinatorial therapies that involve administering an inhibitor of CHI3L1 alongside an immune checkpoint inhibitor. Additionally, he has developed methods and compositions relating to anti-CHI3L1 antibodies that exhibit superior properties such as high sensitivity, specificity, and binding affinity, as well as neutralizing activity both in vitro and in vivo. His work aims at treating various conditions including cancer, obesity, and asthma.
Career Highlights
Bing Ma has had a distinguished career, contributing his expertise at prestigious institutions such as Brown University and Yale University. His research endeavors have profoundly impacted cancer treatment methodologies, showcasing his dedication to advancing medical science through innovation.
Collaborations
Throughout his career, Ma has collaborated with notable colleagues including Jack A. Elias and Chun Geun Lee. These partnerships have enriched his research and facilitated the development of cutting-edge therapeutic approaches.
Conclusion
Bing Ma's innovative contributions are paving the way for new cancer treatment strategies. His impressive patent portfolio reflects a commitment to improving patient outcomes through scientific discovery and collaboration. As the field of oncology continues to evolve, Ma's work remains at the forefront of transformative therapies, underscoring the importance of innovation in healthcare.